Stansberry Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,474	Closed	-$119K	–	129
2024 Q4	$119K	Sell	40,474 -43,463	-52%	-$121K	0.02%	123
2024 Q3	$218K	Sell	83,937 -4,473	-5%	-$12.4K	0.03%	124
2024 Q2	$262K	Sell	88,410 -4,878	-5%	-$18.5K	0.03%	122
2024 Q1	$423K	Sell	93,288 -6,698	-7%	-$34.2K	0.06%	110
2023 Q4	$571K	Sell	99,986 -12,481	-11%	-$57.8K	0.09%	100
2023 Q3	$517K	Buy	112,467 +9,792	+10%	+$59.6K	0.09%	100
2023 Q2	$663K	Buy	102,675 +1,138	+1%	+$7.77K	0.12%	87
2023 Q1	$766K	Buy	101,537 +1,361	+1%	+$12.4K	0.15%	88
2022 Q4	$1.01M	Buy	100,176 +2,026	+2%	+$23.4K	0.21%	80
2022 Q3	$971K	Sell	98,150 -2,365	-2%	-$25.9K	0.21%	72
2022 Q2	$1.07M	Sell	100,515 -2,448	-2%	-$20.7K	0.23%	68
2022 Q1	$1M	Buy	102,963 +7,048	+7%	+$66.7K	0.18%	79
2021 Q4	$1.37M	Buy	95,915 +56,941	+146%	+$864K	0.26%	59
2021 Q3	$781K	Buy	+38,974	New	+$689K	0.16%	51